Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
32%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
HART
75
HOLDINGS
17%
ALSO IN HRTS
HRTS
43
HOLDINGS
26%
ALSO IN HART
SECTOR DRIFT (HART minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HART |
Weight in HRTS |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 5.4% | 7.8% | 5.4% | |
ABBOTT LABORATORIES | 5.7% | 4.7% | 4.7% | |
ASTRAZENECA PLC | 5.6% | 4.5% | 4.5% | |
BOSTON SCIENTIFIC CORP | 5.4% | 3.9% | 3.9% | |
NOVO NORDISK A/S-B | 4.0% | 3.5% | 3.5% |
HART Overweight Relative to HRTS
JOHNSON & JOHNSON | 5.3% | |
ALPHABET INC. CLASS A | 5.0% | |
PFIZER INC | 5.0% | |
APPLE INC | 4.9% | |
SANOFI-AVENTIS | 4.0% | |
BRISTOL-MYERS SQUIBB CO | 3.0% | |
ELEVANCE HEALTH INC | 2.8% | |
NIKE INC -CL B | 2.7% | |
MEDTRONIC PLC | 2.3% | |
NOVARTIS AG | 2.0% |
HART Underweight Relative to HRTS
UNITEDHEALTH GROUP INC | -4.6% | |
ROCHE HOLDINGS LTD-SPONS ADR | -4.2% | |
ABBVIE INC | -3.5% | |
GILEAD SCIENCES INC | -3.4% | |
THERMO FISHER SCIENTIFIC INC | -3.4% | |
BRIDGEBIO PHARMA, INC. | -2.9% | |
CRINETICS PHARMACEUTICALS INC | -2.6% | |
MERCK & CO. INC. | -2.6% | |
VERTEX PHARMACEUTICALS INC | -2.6% | |
AMGEN INC | -2.5% |